Your browser doesn't support javascript.
loading
Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking.
Nii, Takuro; Kuzuya, Kentaro; Kabata, Daijiro; Matsui, Toshihiro; Murata, Atsuko; Ohya, Takeshi; Matsuoka, Hidetoshi; Shimizu, Takashi; Oguro, Eri; Okita, Yasutaka; Udagawa, Chikako; Yoshimura, Maiko; Kudo-Tanaka, Eriko; Teshigawara, Satoru; Harada, Yoshinori; Yoshida, Yuji; Isoda, Kentaro; Tsuji, So-Ichiro; Ohshima, Shiro; Hashimoto, Jun; Shintani, Ayumi; Takehana, Yasuo; Tohma, Shigeto; Saeki, Yukihiko.
Afiliação
  • Nii T; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan; Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Kuzuya K; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Kabata D; Medical Statics, Osaka City University Graduate School of Medicine, Asahi-cho, Abeno, Osaka City, Osaka, 545-8585, Japan.
  • Matsui T; Rheumatology, NHO Sagamihara Hospital, Sakura-dai, Minami-ku, Sagamihara City, Kanagawa, 252-0392, Japan.
  • Murata A; Clinical Research, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Ohya T; Clinical Research, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Matsuoka H; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Shimizu T; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan; Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Yamada-oka, Suita, Osaka, 565-0871, Japan.
  • Oguro E; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Okita Y; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Udagawa C; Clinical Research, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan; Molecular Chemistry, Faculty of Pharmacy, Osaka Ohtani University, Nishikiori-kita, Tondabayashi, Osaka, 584-8540, Japan.
  • Yoshimura M; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Kudo-Tanaka E; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Teshigawara S; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Harada Y; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Yoshida Y; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Isoda K; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Tsuji SI; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Ohshima S; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Hashimoto J; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan.
  • Shintani A; Medical Statics, Osaka City University Graduate School of Medicine, Asahi-cho, Abeno, Osaka City, Osaka, 545-8585, Japan.
  • Takehana Y; KISSEI Pharmaceutical CO., LTD., Yoshino, Matsumoto City, Nagano Prefecture 399-8710, Japan.
  • Tohma S; Rheumatology, NHO Tokyo Hospital, Take-oka, Kiyose City, Tokyo, 204-8585, Japan.
  • Saeki Y; Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan; Clinical Research, NHO Osaka Minami Medical Center, Kidohigasi-machi, Kawachinagano, Osaka, 586-8521, Japan. Electronic address: .saekiy@ommc-hp.jp.
J Autoimmun ; 98: 95-102, 2019 03.
Article em En | MEDLINE | ID: mdl-30591403
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Linfócitos T / Sistema de Registros / NF-kappa B / Fator de Necrose Tumoral alfa / Receptores de Hidrocarboneto Arílico / Antirreumáticos / Suspensão de Tratamento / Inibidores de Proteínas Quinases / Infliximab País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Linfócitos T / Sistema de Registros / NF-kappa B / Fator de Necrose Tumoral alfa / Receptores de Hidrocarboneto Arílico / Antirreumáticos / Suspensão de Tratamento / Inibidores de Proteínas Quinases / Infliximab País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão